Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Powassan Virus-A New Reemerging Tick-Borne Disease
Front Public Health 5:342, Fatmi,S.S., et al, 2017
Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013
Weight Change and Antiepileptic Drugs. Health Issues and Criteria for Appropriate Selection of an Antiepileptic Agent.
The Neurologist 12:163-167, Biton,V., 2006
Epilepsy Syndromes in Infancy
Pediatr Neurol 34:253-263, Korff,C.M. &Nordii,D.R.,Jr., 2006
Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001
Drug-Induced Pseudolymphoma Secondary to Lamotrigine
Neurol 50:1509-1510, Pathak,P.&McLachlan,R.S., 1998
Carbamazepine and Fatal Eosinophilic Myocarditis
NEJM 336:878-879, Salzman,M.B.,et al, 1997
Status Epilepticus in Children with Epilepsy:The Role of Antiepileptic Drug Levels in Prevention
Pediatrics 98:1119-1121, Maytal,J.,et al, 1996
Carbamazepine Hypersensitivity Syndrome:Report of 4 Cases & Review of Literature
Medicine 74:144-151, DeVriese,A.S.P.,et al, 1995
The Nondystrophic Myotonias
In Myology, McGraw-Hill, 2nd Ed, Ch49, p1291-13024., Rudel,R.,et al, 1994
Suppression of Carbamazepine-Induced Rash with Prednisone
Neurol 41:144-145, Murphy,J.M.,et al, 1991
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
Vigabatrin in the Treatment of Epilepsy:A Long-Term Follow-Up Study
JNNP 52:467-471, Tartara,A.,et al, 1989